The physiological roles of secretin and its receptor

Annals of Translational Medicine

Volumn 1, Issue 3, 2013, Pages

  Afroze, Syeda ^a   Meng, Fanyin ^a,b,c   Jensen, Kendal ^a   McDaniel, Kelly ^b   Rahal, Kinan ^a   Onori, Paolo ^d   Gaudio, Eugenio ^e   Alpini, Gianfranco ^a,b,c   Glaser, Shannon S ^a,b,c  

^a Gastroenterology Division   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Secretin; Secretin receptors

Indexed keywords

EID: 85015481254     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2012.12.01     Document Type: Article

References (135)

1. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902;28:325-53.
2. Häcki WH. Secretin. Clin Gastroenterol 1980;9:609-32.
3. Alpini G, Glaser S, Robertson W, et al. Large but not small intrahepatic bile ducts are involved in secretin-regulated ductal bile secretion. Am J Physiol 1997;272:G1064-74.
4. Chu JY, Cheng CY, Lee VH, et al. Secretin and body fluid homeostasis. Kidney Int 2011;79:280-7.
5. Dong M, Miller LJ. Molecular pharmacology of the secretin receptor. Receptors Channels 2002;8:189-200.
6. Ishiguro H, Yamamoto A, Nakakuki M, et al. Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium. Nagoya J Med Sci 2012;74:1-18.
7. Alpini G, Lenzi R, Sarkozi L, et al. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 1988;81:569-78.
8. Alpini G, Ulrich CD 2nd, Phillips JO, et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 1994;266:G922-8.
9. McKay T, Reynolds P, Jezzard S, et al. Secretin-mediated gene delivery, a specific targeting mechanism with potential for treatment of biliary and pancreatic disease in cystic fibrosis. Mol Ther 2002;5:447-54.
10. Chow BK, Cheung KH, Tsang EM, et al. Secretin controls anion secretion in the rat epididymis in an autocrine/paracrine fashion. Biol Reprod 2004;70:1594-9.
11. Onori P, Wise C, Gaudio E, et al. Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor. Int J Cancer 2010;127:43-54.
12. Schubert ML. Hormonal regulation of gastric acid secretion. Curr Gastroenterol Rep 2008;10:523-7.
13. Alpini G, Ueno Y, Glaser SS, et al. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 2001;34:868-76.
14. Nishijima I, Yamagata T, Spencer CM, et al. Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior. Hum Mol Genet 2006;15:3241-50.
15. Siu FK, Lam IP, Chu JY, et al. Signaling mechanisms of secretin receptor. Regul Pept 2006;137:95-104.
16. Yamagata T, Urano H, Weeber EJ, et al. Impaired hippocampal synaptic function in secretin deficient mice. Neuroscience 2008;154:1417-22.
17. Glaser S, Lam IP, Franchitto A, et al. Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation. Hepatology 2010;52:204-14.
18. Portela-Gomes GM, Johansson H, Olding L, et al. Colocalization of neuroendocrine hormones in the human fetal pancreas. Eur J Endocrinol 1999;141:526-33.
19. Mutt V, Jorpes JE, Magnusson S. Structure of porcine secretin. The amino acid sequence. Eur J Biochem 1970;15:513-9.
20. Whitmore TE, Holloway JL, Lofton-Day CE, et al. Human secretin (SCT): gene structure, chromosome location, and distribution of mRNA. Cytogenet Cell Genet 2000;90:47-52.
21. Lan MS, Kajiyama W, Donadel G, et al. cDNA sequence and genomic organization of mouse secretin. Biochem Biophys Res Commun 1994;200:1066-71.
22. Bonetto V, Jörnvall H, Mutt V, et al. Two alternative processing pathways for a preprohormone: a bioactive form of secretin. Proc Natl Acad Sci U S A 1995;92:11985-9.
23. Gafvelin G, Jörnvall H, Mutt V. Processing of prosecretin: isolation of a secretin precursor from porcine intestine. Proc Natl Acad Sci U S A 1990;87:6781-5.
24. Kopin AS, Wheeler MB, Leiter AB. Secretin: structure of the precursor and tissue distribution of the mRNA. Proc Natl Acad Sci U S A 1990;87:2299-303.
25. Williams RH. eds. Textbook of endocrinology. 6th ed. Philadelphia: Saunders, 1981: xxiii, 1270.
26. DeGroot LJ. eds. Endocrinology. 2nd ed. Philadelphia: Saunders, 1989.
27. Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010;5:725-38.
28. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008;9:40.
29. Polak JM, Coulling I, Bloom S, et al. Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa. Scand J Gastroenterol 1971;6:739-44.
30. Samson WK, Lumpkin MD, Vijayan E, et al. Gastrointestinal hormones: central nervous system localization and sites of neuroendocrine actions. Endocrinol Exp 1982;16:177-89.
31. Wang T, Palkovits M, Rusnak M, et al. Distribution of parathyroid hormone-2 receptor-like immunoreactivity and messenger RNA in the rat nervous system. Neuroscience 2000;100:629-49.
32. Charlton CG, O'Donohue TL, Miller RL, et al. Secretin immunoreactivity in rat and pig brain. Peptides 1981;2:45-9.
33. Samson WK, Lumpkin MD, McCann SM. Presence and possible site of action of secretin in the rat pituitary and hypothalamus. Life Sci 1984;34:155-63.
34. Fremeau RT Jr, Jensen RT, Charlton CG, et al. Secretin: specific binding to rat brain membranes. J Neurosci 1983;3:1620-5.
35. Yung WH, Leung PS, Ng SS, et al. Secretin facilitates GABA transmission in the cerebellum. J Neurosci 2001;21:7063-8.
36. Ohta M, Funakoshi S, Kawasaki T, et al. Tissue-specific expression of the rat secretin precursor gene. Biochem Biophys Res Commun 1992;183:390-5.
37. Glaser S, Gaudio E, Onori P, et al. Knockout of the gene for secretin inhibits biliary hyperplasia of large cholangiocytes in cholestatic mice by an autocrine mechanism. Hepatology 2009;50:A1075.
38. Ishihara T, Nakamura S, Kaziro Y, et al. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J 1991;10:1635-41.
39. Kopin AS, Wheeler MB, Nishitani J, et al. The secretin gene: evolutionary history, alternative splicing, and developmental regulation. Proc Natl Acad Sci U S A 1991;88:5335-9.
40. Carstairs JR, Barnes PJ. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. J Pharmacol Exp Ther 1986;239:249-55.
41. Charlton CG, Quirion R, Handelmann GE, et al. Secretin receptors in the rat kidney: adenylate cyclase activation and renal effects. Peptides 1986;7:865-71.
42. Christophe J, Waelbroeck M, Chatelain P, et al. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides 1984;5:341-53.
43. Fremeau RT Jr, Korman LY, Moody TW. Secretin stimulates cyclic AMP formation in the rat brain. J Neurochem 1986;46:1947-55.
44. Isenberg JI, Wallin B, Johansson C, et al. Secretin, VIP, and PHI stimulate rat proximal duodenal surface epithelial bicarbonate secretion in vivo. Regul Pept 1984;8:315-20.
45. Christodoulopoulos JB, Jacobs WH, Klotz AP. Action of secretin on pancreatic secretion. Am J Physiol 1961;201:1020-4.
46. Jones RS, Geist RE, Hall AD. The choleretic effects of glucagon and secretin in the dog. Gastroenterology 1971;60:64-8.
47. Sanders MJ, Amirian DA, Ayalon A, et al. Regulation of pepsinogen release from canine chief cells in primary monolayer culture. Am J Physiol 1983;245:G641-6.
48. Straus E, Greenstein AJ, Yalow RS. Effect of secretin on release of heterogeneous forms of gastrin. Gut 1975;16:999-1005.
49. Hubel KA. Secretin: a long progress note. Gastroenterology 1972;62:318-41.
50. Kraegen EW, Chisholm DJ, Young JD, et al. The gastrointestinal stimulus to insulin release. II. A dual action of secretin. J Clin Invest 1970;49:524-9.
51. Patel DR, Kong Y, Sreedharan SP. Molecular cloning and expression of a human secretin receptor. Mol Pharmacol 1995;47:467-73.
52. Davis RJ, Page KJ, Dos Santos Cruz GJ, et al. Expression and functions of the duodenal peptide secretin and its receptor in human lung. Am J Respir Cell Mol Biol 2004;31:302-8.
53. Yuan Y, Lee LT, Ng SS, et al. Extragastrointestinal functions and transcriptional regulation of secretin and secretin receptors. Ann N Y Acad Sci 2011;1220:23-33.
54. Tay J, Goulet M, Rusche J, et al. Age-related and regional differences in secretin and secretin receptor mRNA levels in the rat brain. Neurosci Lett 2004;366:176-81.
55. Steiner TS, Mangel AW, McVey DC, et al. Secretin receptors mediating rat forestomach relaxation. Am J Physiol 1993;264:G863-7.
56. Alpini G, Glaser SS, Ueno Y, et al. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol 1998;274:G767-75.
57. Alpini G, Roberts S, Kuntz SM, et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 1996;110:1636-43.
58. Alpini G, Ulrich C, Roberts S, et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol 1997;272:G289-97.
59. Farouk M, Vigna SR, McVey DC, et al. Localization and characterization of secretin binding sites expressed by rat bile duct epithelium. Gastroenterology 1992;102:963-8.
60. Farouk M, Vigna SR, Haebig JE, et al. Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary epithelium. J Surg Res 1993;54:1-6.
61. Kato A, Gores GJ, LaRusso NF. Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem 1992;267:15523-9.
62. Lesage G, Glaser S, Ueno Y, et al. Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am J Physiol Gastrointest Liver Physiol 2001;281:G182-90.
63. LeSage GD, Benedetti A, Glaser S, et al. Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. Hepatology 1999;29:307-19.
64. LeSage GD, Glaser SS, Marucci L, et al. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. Am J Physiol 1999;276:G1289-301.
65. Mancinelli R, Franchitto A, Gaudio E, et al. After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes. Am J Pathol 2010;176:1790-800.
66. Wang X, Ye H, Ward CJ, et al. Insignificant effect of secretin in rodent models of polycystic kidney and liver disease. Am J Physiol Renal Physiol 2012;303:F1089-98.
67. Körner M, Hayes GM, Rehmann R, et al. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol 2006;45:825-35.
68. Alvaro D, Cho WK, Mennone A, et al. Effect of secretion on intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest 1993;92:1314-25.
69. Soleimani M. Impaired pancreatic ductal bicarbonate secretion in cystic fibrosis. JOP 2001;2:237-42.
70. Tietz PS, Alpini G, Pham LD, et al. Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. Am J Physiol 1995;269:G110-8.
71. Caligiuri A, Glaser S, Rodgers RE, et al. Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. Am J Physiol 1998;275:G835-46.
72. Glaser SS, Rodgers RE, Phinizy JL, et al. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol 1997;273:G1061-70.
73. Francis H, LeSage G, DeMorrow S, et al. The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretinstimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats. Am J Physiol Cell Physiol 2007;293:C1252-62.
74. LeSage GD, Alvaro D, Glaser S, et al. Alpha-1 adrenergic receptor agonists modulate ductal secretion of BDL rats via Ca(2+)- and PKC-dependent stimulation of cAMP. Hepatology 2004;40:1116-27.
75. Ding WQ, Cheng ZJ, McElhiney J, et al. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res 2002;62:5223-9.
76. Körner MU, Hayes GM, Carrigan PE, et al. Wildtype and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. Mod Pathol 2008;21:387-95.
77. Ding WQ, Kuntz S, Böhmig M, et al. Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. Gastroenterology 2002;122:500-11.
78. Körner M, Hayes GM, Rehmann R, et al. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia. Am J Pathol 2005;167:959-68.
79. Li P, Chang TM, Chey WY. Secretin inhibits gastric acid secretion via a vagal afferent pathway in rats. Am J Physiol 1998;275:G22-8.
80. Shimizu K, Li P, Lee KY, et al. The mechanism of inhibitory action of secretin on gastric acid secretion in conscious rats. J Physiol 1995;488:501-8.
81. Chung I, Li P, Lee K, et al. Dual inhibitory mechanism of secretin action on acid secretion in totally isolated, vascularly perfused rat stomach. Gastroenterology 1994;107:1751-8.
82. Jordan PH Jr, Peterson ND. Effects of secretin upon gastric secretion. Ann Surg 1962;156:914-23.
83. Osnes M, Hanssen LE, Flaten O, et al. Exocrine pancreatic secretion and immunoreactive secretin (IRS) release after intraduodenal instillation of bile in man. Gut 1978;19:180-4.
84. Rominger JM, Chey WY, Chang TM. Plasma secretin concentrations and gastric pH in healthy subjects and patients with digestive diseases. Dig Dis Sci 1981;26:591-7.
85. Pascua P, García M, Fernández-Salazar MP, et al. Ducts isolated from the pancreas of CFTR-null mice secrete fluid. Pflugers Arch 2009;459:203-14.
86. Cheng CY, Chu JY, Chow BK. Vasopressin-independent mechanisms in controlling water homeostasis. J Mol Endocrinol 2009;43:81-92.
87. Nielsen S, DiGiovanni SR, Christensen EI, et al. Cellular and subcellular immunolocalization of vasopressinregulated water channel in rat kidney. Proc Natl Acad Sci U S A 1993;90:11663-7.
88. Nielsen S, Chou CL, Marples D, et al. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A 1995;92:1013-7.
89. Baron DN, Newman F, Warrick A. The effects of secretin on urinary volume and electrolytes in normal subjects and patients with chronic pancreatic disease. Experientia 1957;14:30-32.
90. Viteri AL, Poppell JW, Lasater JM, et al. Renal response to secretin. J Appl Physiol 1975;38:661-4.
91. Waldum HL, Sundsfjord JA, Aanstad U, et al. The effect of secretin on renal haemodynamics in man. Scand J Clin Lab Invest 1980;40:475-8.
92. Barbezat GO, Isenberg JI, Grossman MI. Diuretic action of secretin in dog. Proc Soc Exp Biol Med 1972;139:211-5.
93. Lossi L, Bottarelli L, Candusso ME, et al. Transient expression of secretin in serotoninergic neurons of mouse brain during development. Eur J Neurosci 2004;20:3259-69.
94. Yang B, Goulet M, Boismenu R, et al. Secretin depolarizes nucleus tractus solitarius neurons through activation of a nonselective cationic conductance. Am J Physiol Regul Integr Comp Physiol 2004;286:R927-34.
95. Campbell G. Cotransmission. Annu Rev Pharmacol Toxicol 1987;27:51-70.
96. Guyton AC. eds. Rythmical excitation of the heart. Human Physiolology of Mechanisms of Disease, 5 ed. Philadelphia: Saunders, 1992:89-94.
97. Hökfelt T, Johansson O, Ljungdahl A, et al. Peptidergic neurones. Nature 1980;284:515-21.
98. Gozes I, Brenneman DE. VIP: molecular biology and neurobiological function. Mol Neurobiol 1989;3:201-36.
99. Chatelain P, Robberecht P, de Neef P, et al. Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats. FEBS Lett 1979;107:86-90.
100. Robberecht P, Gillet L, Chatelain P, et al. Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats. Peptides 1984;5:355-8.
101. Chatelain P, Robberecht P, De Neef P, et al. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat. Pflugers Arch 1981;390:10-6.
102. Ross G. Cardiovascular effects of secretin. Am J Physiol 1970;218:1166-70.
103. Chiba S. Effect of secretin on pacemaker activity and contractility in the isolated blood-perfused atrium of the dog. Clin Exp Pharmacol Physiol 1976;3:167-72.
104. Kanno N, LeSage G, Glaser S, et al. Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 2001;281:G612-25.
105. Francis H, Glaser S, Ueno Y, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 2004;41:528-37.
106. Banales JM, Arenas F, Rodríguez-Ortigosa CM, et al. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology 2006;43:266-75.
107. Glaser SS, Gaudio E, Rao A, et al. Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest 2009;89:456-69.
108. Woo K, Sathe M, Kresge C, et al. Adenosine triphosphate release and purinergic (P2) receptor-mediated secretion in small and large mouse cholangiocytes. Hepatology 2010;52:1819-28.
109. Dutta AK, Khimji AK, Kresge C, et al. Identification and functional characterization of TMEM16A, a Ca2+-activated Cl- channel activated by extracellular nucleotides, in biliary epithelium. J Biol Chem 2011;286:766-76.
110. Kaminski DL, Deshpande YG. Effect of somatostatin and bombesin on secretin-stimulated ductular bile flow in dogs. Gastroenterology 1983;85:1239-47.
111. Glaser S, Alvaro D, Ueno Y, et al. Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. Liver Int 2003;23:78-88.
112. Alpini G, Elias I, Glaser SS, et al. gamma-Interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis. J Hepatol 1997;27:371-80.
113. Lesage GD, Marucci L, Alvaro D, et al. Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity. Hepatology 2002;36:641-51.
114. Glaser S, Alvaro D, Roskams T, et al. Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. Am J Physiol Gastrointest Liver Physiol 2003;284:G683-94.
115. Alvaro D, Alpini G, Jezequel AM, et al. Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. J Clin Invest 1997;100:1349-62.
116. LeSagE G, Alvaro D, Benedetti A, et al. Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology 1999;117:191-9.
117. Marzioni M, LeSage GD, Glaser S, et al. Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. Am J Physiol Gastrointest Liver Physiol 2003;284:G837-52.
118. Marzioni M, Francis H, Benedetti A, et al. Ca2+- dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts. Am J Pathol 2006;168:398-409.
119. Glaser S, Alvaro D, Francis H, et al. Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. Am J Physiol Gastrointest Liver Physiol 2006;290:G813-26.
120. Marzioni M, Ueno Y, Glaser S, et al. Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver. Liver Int 2007;27:558-68.
121. Mancinelli R, Onori P, Gaudio E, et al. Taurocholate feeding to bile duct ligated rats prevents caffeic acidinduced bile duct damage by changes in cholangiocyte VEGF expression. Exp Biol Med (Maywood) 2009;234:462-74.
122. Ueno Y, Francis H, Glaser S, et al. Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. Exp Biol Med (Maywood) 2007;232:942-9.
123. Strazzabosco M, Fiorotto R, Melero S, et al. Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation. Hepatology 2009;50:244-52.
124. Alpini G, Ulrich C, Roberts S, et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol 1997;272:G289-97.
125. Renzi A, Demorrow S, Onori P, et al. Modulation of the biliary expression of arylalkylamine N-acetyltransferase alters the autocrine proliferative responses of cholangiocytes. Hepatology 2013;57:1130-41.
126. Yang F, Priester S, Onori P, et al. Castration inhibits biliary proliferation induced by bile duct obstruction: novel role for the autocrine trophic effect of testosterone. Am J Physiol Gastrointest Liver Physiol 2011;301:G981-91.
127. Mancinelli R, Onori P, Gaudio E, et al. Folliclestimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1. Am J Physiol Gastrointest Liver Physiol 2009;297:G11-26.
128. Prieto J, García N, Martí-Climent JM, et al. Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology 1999;117:167-72.
129. Hellund JC, Geitung JT, Meo AM, et al. Secretin stimulated magnetic resonance cholangiopancreatography in diseases of the biliary and pancreatic ducts. Tidsskr Nor Laegeforen 2002;122:691-4.
130. Czakó L, Takács T, Morvay Z, et al. Diagnostic role of secretin-enhanced MRCP in patients with unsuccessful ERCP. World J Gastroenterol 2004;10:3034-8.
131. Hohenester S, Maillette de Buy Wenniger L, Jefferson DM, et al. Biliary bicarbonate secretion constitutes a protective mechanism against bile acid-induced injury in man. Dig Dis 2011;29:62-5.
132. Hohenester S, Wenniger LM, Paulusma CC, et al. A biliary HCO3-umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 2012;55:173-83.
133. Erlinger S. Chronic fibrosing cholangiopathies: a consequence of a defective HCO3-"umbrella"? Clin Res Hepatol Gastroenterol 2011;35:85-8.
134. Beuers U, Hohenester S, de Buy Wenniger LJ, et al. The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010;52:1489-96.
135. Banales JM, Sáez E, Uriz M, et al. Up-regulation of microRNA 506 leads to decreased Cl-/HCO3-anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012;56:687-97.